Clinical Trial Update: A Prospective Cluster-Randomized, Controlled Crossover Trial to Validate an Electronic "Resistance Calculator"

View source ↗

Summary

A prospective cluster-randomized, controlled crossover trial is planned to validate an electronic 'Resistance Calculator' for sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Dror MarChaim, MD | Conditions: Sepsis | Status: RECRUITING